Real-world experience of ocrelizumab in multiple sclerosis patients in Latin America.

Juan Ignacio Rojas Liliana Patrucco Manuel FrunsGiesela HornungJosé Flores Edgar Carnero Contentti Pablo Adrian Lopez Juan Pablo Pettinicchi Alejandro Caride Lorna Galleguillos Jorge BarahonaVioleta DiazMaría Álvarez Hernández Ricardo Alonso Edgardo Cristiano

Published in: Arquivos de neuro-psiquiatria (2021)

Our study is in line with previous randomized clinical trials and recent real-world studies describing patient profiles, effectiveness and persistence regarding ocrelizumab treatment in multiple sclerosis patients in Latin America.

Keyphrases

multiple sclerosis
end stage renal disease
ejection fraction
newly diagnosed
randomized controlled trial